These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37771991)

  • 1. Retracted: Antitumor Activity of lncRNA NBAT-1 via Inhibition of miR-4504 to Target to WWC3 in Oxaliplatin-Resistant Colorectal Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9894540. PubMed ID: 37771991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor Activity of lncRNA NBAT-1 via Inhibition of miR-4504 to Target to WWC3 in Oxaliplatin-Resistant Colorectal Carcinoma.
    Li C; Li X
    J Healthc Eng; 2022; 2022():9121554. PubMed ID: 35494512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA-NBAT-1 modulates esophageal cancer proliferation via PKM2.
    Zhao B; Cao P; Hu S; Li F; Kong K; Zu Y
    Am J Transl Res; 2019; 11(9):5978-5987. PubMed ID: 31632565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA NBAT-1 is down-regulated in lung cancer and influences cell proliferation, apoptosis and cell cycle.
    Lei T; Lv ZY; Fu JF; Wang Z; Fan Z; Wang Y
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1958-1962. PubMed ID: 29687849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2.
    Li P; Zhang X; Wang H; Wang L; Liu T; Du L; Yang Y; Wang C
    Mol Cancer Ther; 2017 Apr; 16(4):739-751. PubMed ID: 28069878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_WWC3 overexpression decelerates the progression of osteosarcoma by regulating miR-421/PDE7B axis.
    Liu S; Zhang J; Zheng T; Mou X; Xin W
    Open Life Sci; 2021; 16(1):229-241. PubMed ID: 33817314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: LncRNA-URHC Functions as ceRNA to Regulate DNAJB9 Expression by Competitively Binding to miR-5007-3p in Hepatocellular Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9789637. PubMed ID: 37387927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: LncRNA Gm43843 Promotes Cardiac Hypertrophy via miR-153-3p/Cacna1c Axis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9841426. PubMed ID: 37593037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA NBAT-1 suppresses tumorigenesis and predicts favorable prognosis in ovarian cancer.
    Yan C; Jiang Y; Wan Y; Zhang L; Liu J; Zhou S; Cheng W
    Onco Targets Ther; 2017; 10():1993-2002. PubMed ID: 28435289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRF-1 mediated long non-coding RNA PVT1-214 promotes oxaliplatin resistance of colorectal cancer via miR-128 inhibition.
    Tong D; Zou E; Bai L; Ma J; Guo N; Wang H; Jiang L
    J BUON; 2020; 25(5):2205-2214. PubMed ID: 33277837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: lncRNA GHET1 Promotes the Progression of Triple-Negative Breast Cancer via Regulation of miR-377-3p/GRSF1 Signaling Axis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9785034. PubMed ID: 37416294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA PCGEM1 mediates oxaliplatin resistance in hepatocellular carcinoma via miR-129-5p/ETV1 axis in vitro.
    Chen J; Yuan D; Hao Q; Zhu D; Chen Z
    Adv Clin Exp Med; 2021 Aug; 30(8):831-838. PubMed ID: 34286514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Xue S; Li QW; Che JP; Guo Y; Yang FQ; Zheng JH
    Int J Clin Exp Pathol; 2015; 8(4):3765-74. PubMed ID: 26097558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: LncRNA-PAX8-AS1 Silencing Decreases Cell Viability, Enhances Apoptosis, and Suppresses Doxorubicin Resistance in Myeloid Leukemia via the miR-378g/ERBB2 Axis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9829428. PubMed ID: 37387868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363.
    Huang H; Chen J; Ding CM; Jin X; Jia ZM; Peng J
    J Cell Mol Med; 2018 Jun; 22(6):3238-3245. PubMed ID: 29602203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: The Effect of lncRNA SNHG3 Overexpression on Lung Adenocarcinoma by Regulating the Expression of miR-890.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9761493. PubMed ID: 37593475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: lncRNA MSC-AS1 Aggravates Diabetic Nephropathy by Regulating the miR-325/CCNG1 Axis.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9825754. PubMed ID: 37593467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: lncRNA FOXD2-AS1 Promotes the Retinoblastoma Cell Viability and Migration by Sponging miR-31.
    International BR
    Biomed Res Int; 2023; 2023():9802968. PubMed ID: 37539018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: lncRNA-SNHG14 Promotes Atherosclerosis by Regulating ROR
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9894214. PubMed ID: 37771404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.